Catalent, Inc. (CTLT) CEO John Chiminski on Q3 2022 Results

Catalent, Inc. (NYSE:NYSE:CTLT) Q3 2022 Earnings Conference Call May 3, 2022 8:15 AM ET Company Participants Paul Surdez - Vice President, Investor Relations John Chiminski - Chair and...

Related Keywords

New Jersey , United States , Belgium , United Kingdom , Russia , Gosselies , Waals Gewest , Brussels , Bruxelles Capitale , Ukraine , Russian , America , British , Dave Windley , Jack Meehan , Jacob Johnson , Julia Qin , Justin Bowers , Tom Castellano , Paul Surdez , John Chiminski , John Sourbeer , Luke Sergott , Erytech Pharma , Alessandro Maselli , Thomas Castellano , Company Participants , Morgan Stanley , Stephens Inc , Plasmid Center , Barclays Capital , Deutsche Bank , Catalent Inc , Barclays , Nephron Research , Conference Call May , Chief Executive , Chief Operating , Vice President , Chief Financial , Third Quarter Fiscal Year , Investor Relations , Chief Executive Officer , Chief Operating Officer , Senior Vice President , Oral Technologies , Specialty Delivery , Kansas City , Cell Therapy , Annual Corporate Responsibility Report , Responsibility Report , Climate Related Financial Disclosure , Executive Chair , Tejas Savant , Green Brownfield , North America , Sean Dodge ,